Robot | Path | Permission |
GoogleBot | / | ✔ |
BingBot | / | ✔ |
BaiduSpider | / | ✔ |
YandexBot | / | ✔ |
Title | Kymab |
Description | Sanofi and Kymab have joined forces to bring new medicines to Kymab, based in Cambridge, UK, is working independently and with partners to provide novel solutions in drug and vaccine development. Using our unique technology, we rapidly develop broad diversity, high-quality human antibodies for treating |
Keywords | N/A |
WebSite | kymab.com |
Host IP | 178.62.11.133 |
Location | United Kingdom |
Site | Rank |
US$4,908,972
Last updated: 2022-06-27 07:35:51
kymab.com has Semrush global rank of 2,156,114. kymab.com has an estimated worth of US$ 4,908,972, based on its estimated Ads revenue. kymab.com receives approximately 566,420 unique visitors each day. Its web server is located in United Kingdom, with IP address 178.62.11.133. According to SiteAdvisor, kymab.com is safe to visit. |
Purchase/Sale Value | US$4,908,972 |
Daily Ads Revenue | US$4,532 |
Monthly Ads Revenue | US$135,941 |
Yearly Ads Revenue | US$1,631,290 |
Daily Unique Visitors | 37,762 |
Note: All traffic and earnings values are estimates. |
Host | Type | TTL | Data |
kymab.com. | A | 900 | IP: 178.62.11.133 |
kymab.com. | NS | 900 | NS Record: ns3.sanofi-synthelabo.com. |
kymab.com. | NS | 900 | NS Record: ns4.sanofi-synthelabo.com. |
kymab.com. | NS | 900 | NS Record: ns1.sanofi-synthelabo.com. |
kymab.com. | NS | 900 | NS Record: ns2.sanofi-synthelabo.com. |
kymab.com. | MX | 900 | MX Record: 10 eu-smtp-inbound-1.mimecast.com. |
kymab.com. | MX | 900 | MX Record: 10 eu-smtp-inbound-2.mimecast.com. |
kymab.com. | TXT | 900 | TXT Record: v=spf1 mx a a:o10.mail.cascadecloud.co.uk include:_netblocks.mimecast.com include:spf.mandrillapp.com include:email.freshdesk.com ~all |
We use cookies on our website. Carry on browsing if you’re happy with this or find out more Home About us Back About us People Our history Pipeline Back Pipeline Amlitelimab SAR445229 (formerly KY1005) Alomfilimab SAR445256 (formerly KY1044) Download pipeline Therapeutic areas Back Therapeutic areas Immune diseases Immuno-oncology Haematology Infectious disease Technology Back Technology IntelliSelect® Antibody Development Bispecific antibodies Innovative Antibodies Publications Careers Back Careers Life at Kymab Our Location Current vacancies Contact Press enter to search Sanofi and Kymab have joined forces to bring new medicines to patients Read the press release Unique antibodies, unique solutions Our unique technologies drive the rapid development of effective, human antibody-based drugs across our four main therapeutic areas - immuno-oncology, inflammation, haematology and infectious disease. View our pipeline Our unique platforms can deliver the finest novel therapeutic |
HTTP/1.1 301 Moved Permanently Server: nginx/1.18.0 (Ubuntu) Date: Mon, 25 Oct 2021 20:36:53 GMT Content-Type: text/html Content-Length: 178 Connection: keep-alive Location: https://kymab.com/ HTTP/2 301 server: nginx date: Mon, 25 Oct 2021 20:36:53 GMT content-type: text/html; charset=utf-8 content-length: 0 location: https://www.kymab.com/ HTTP/2 200 server: nginx date: Mon, 25 Oct 2021 20:36:54 GMT content-type: text/html; charset=utf-8 content-length: 29654 x-frame-options: SAMEORIGIN vary: Cookie expires: Mon, 25 Oct 2021 20:37:59 GMT cache-control: max-age=300 |
Domain Name: KYMAB.COM Registry Domain ID: 1568823750_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.corporatedomains.com Registrar URL: http://cscdbs.com Updated Date: 2021-09-06T04:32:55Z Creation Date: 2009-09-12T14:54:37Z Registry Expiry Date: 2023-09-12T14:54:37Z Registrar: CSC Corporate Domains, Inc. Registrar IANA ID: 299 Registrar Abuse Contact Email: domainabuse@cscglobal.com Registrar Abuse Contact Phone: 8887802723 Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Name Server: NS1.SANOFI-SYNTHELABO.COM Name Server: NS2.SANOFI-SYNTHELABO.COM Name Server: NS3.SANOFI-SYNTHELABO.COM Name Server: NS4.SANOFI-SYNTHELABO.COM DNSSEC: unsigned >>> Last update of whois database: 2021-09-13T22:44:32Z <<< |